Is Theravance Biopharma, Inc. technically bullish or bearish?

As of 31 October 2025, the technical trend for Theravance Biopharma, Inc. has changed from mildly bullish to bullish. The current stance is bullish, supported by daily moving averages and bullish signals from Bollinger Bands and KST across both weekly and monthly time frames. However, the MACD is mildly bearish on the weekly and bullish on the monthly, while the RSI shows a bearish signal on the monthly. Dow Theory indicates a mildly bearish weekly trend but a mildly bullish monthly trend.
In terms of performance, the stock has outperformed the S&P 500 significantly year-to-date with a return of 55.79% compared to 16.30%, and over the past year with 77.91% against 19.89%. However, over the longer term, the 3-year and 5-year returns are lagging behind the S&P 500. Overall, the current technical stance is bullish but with some mixed signals in the indicators.